Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-20 · accession 0001871155-24-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-20 | CRBU | Fischesser Ryan | VP of Fin, Ctrl | A - Grant | $0.00 | +25.0K | 118.9K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-20 | A | A | 25,000 | $0.00 | 118,854 | D | — | — | (F1) This reflects restricted stock units ("RSUs") that will vest in full on November 20, 2025, subject to the reporting person's continued services to the Issuer through the vesting date. The RSUs will be settled in stock within 30 days after each vesting date. |